Table 3.
Selected laboratory data of COVID-19 patients.
| Characteristics | With HH (n = 3) | Without HH (n = 48) | P-value |
|---|---|---|---|
| BLOOD COUNTS | |||
| WBC (× 109/L) | 9.98 (6.19–15.23) | 9.32 (6.58–14.10) | 0.89 |
| Lymphocyte (× 109/L) | 0.26 (0.20–0.48) | 0.57 (0.34–1.04) | <0.001 |
| Hgb (g/L) | 95.95 (83.90–123.70) | 111.00 (82.85–126.90) | 0.26 |
| PLT (× 109/L) | 64.00 (48.25–147.25) | 151.00 (103.00–219.50) | <0.001 |
| LIVER ENZYMES AND FUNCTION | |||
| ALB (g/L) | 28.95 (24.95–31.28) | 30.70 (27.80–34.35) | 0.02 |
| ALT (U/L) | 42.00 (21.00–54.00) | 40.00 (26.00–69.00) | 0.50 |
| AST (U/L) | 40.00 (34.00–61.00) | 38.00 (26.00–65.00) | 0.23 |
| TBIL (μmol/L) | 21.30 (14.50–32.90) | 14.20 (10.20–21.10) | <0.001 |
| γ-GT (U/L) | 70.50 (43.75–97.00) | 45.00 (24.00–111.00) | 0.07 |
| ALP (U/L) | 100.00 (87.25–120.75) | 90.50 (71.00–122.75) | 0.13 |
| LDH (U/L) | 432.00 (347.25–895.25) | 460.50 (322.25–641.75) | 0.86 |
| INR | 1.26 (1.16–1.43) | 1.22 (1.13–1.36) | 0.14 |
| ADDITIONAL MARKERS OF ORGAN DAMAGE AND INFLAMMATION | |||
| CRP (mg/L) | 235.30 (102.80–300.50) | 53.60 (23.58–112.33) | <0.001 |
| PCT (ng/ml) | 5.43(1.87–20.13) | 0.29(0.06–1.90) | <0.001 |
| D-dimer (μg/L) | 935.00 (622.50–2049.00) | 1123.00 (578.00–3254.00) | 0.61 |
| IL-6 (pg/mL) | 356.10 (149.70–1622.25) | 45.21 (17.90–103.60) | <0.001 |
| Creatinine (μmol/L) | 88.50 (71.00–124.55) | 70.00 (52.53–115.70) | 0.02 |
WBC, white blood cell;Hgb, hemoglobin; PLT, platelet count; ALB, albumin; ALT, alanine aminotransferase; AST, aspartate transaminase; TBIL, total bilirubin; γ-GT, γ-glutamyl transpeptidase; ALP, alkaline phosphatase; LDH, lactic dehydrogenase; INR, international normalized ratio; CRP, C-reactive protein; PCT, procalcitonin; IL-6, interleukin-6.